中文(简体)
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Management of Cardiogenic Pulmonary Edema (RENAU-OAP)

只有注册用户可以翻译文章
登陆注册
链接已保存到剪贴板
状态已终止
赞助商
Centre Hospitalier Annecy Genevois

关键词

抽象

The prevalence of heart failure is estimated to 2.3 percent of the adult population and strongly increases with age, according to french disability-health surveys. In France, more than 32,000 annual deaths are attributable to heart failure and the five-year survival rate is similar to those found in many cancers. A better therapeutic management (angiotensin converting enzyme inhibitor and beta-blockers) helped reduce mortality after an episode of heart failure requiring hospitalization, but, nevertheless it remains high.
The severity of cardiogenic pulmonary edema depends on several factors such as etiology, hemodynamic status, effect on hematosis, and fatigue.
It is important to note that cardiogenic pulmonary edema initial management is decisive. In addition, early and adapted management of cardiogenic pulmonary edema is associated with a shorter hospital stay and reduced hospital mortality.
The Coronary Emergency Network (RESURCOR) within the Northern French Alps Emergency Network (RENAU) is an emergency care system structured in the departments of Isère, Savoie and Haute Savoie. Its main goal is to help improve emergency management by using regional good practice guidelines (www.renau.org). In this context, projects aiming to evaluate professional practices are developed regularly. Since emergency management of cardiogenic pulmonary edema has not been evaluated, the Northern French Alps Emergency Network offers an approach to improve professional practices by defining and disseminating guidelines on cardiogenic pulmonary edema management which will then be assessed.

描述

The prevalence of heart failure is estimated to 2.3 percent of the adult population and strongly increases with age, according to disability-health surveys in France. In recent years, effective treatments (revascularization in percutaneous coronary intervention, circulatory assistance) helped reduce mortality in post-myocardial infarction, which combined with the increase of life expectancy has led to an increase number of patients with chronic heart failure. More than 32,000 annual deaths are attributable to heart failure and the five-year survival rate is similar to those found in cancers of the breast, bladder, colon, ovarian, and prostate. A better therapeutic management (angiotensin converting enzyme inhibitor and beta-blockers) helped reduce mortality after an episode of heart failure requiring hospitalization, but, nevertheless it remains high.

Main clinical manifestations are those of left heart failure, such as cardiogenic pulmonary edema which is a medical emergency. Treatment must take into account pathophysiological aspects of heart failure, etiologies of cardiogenic pulmonary edema and any potential factors or triggers apart from general measures. Two consensus statements and an international recommendation help define therapeutic strategies in this particular situation.

Signs suggestive of cardiogenic pulmonary edema include orthopnea, bilateral crackles or wheezing (patients over 70 years without known asthma), edema of the lower limbs, and gallop sound on heart auscultation. The evolution of these signs makes it particularly possible to manage the response to the treatment. The severity of cardiogenic pulmonary edema depends on several factors such as etiology (ECG analysis and chest pain assessment for acute coronary syndrome), hemodynamic status (blood pressure, heart rate), effect on hematosis (cyanosis, oxygen saturation), and fatigue (low respiratory rate with persistent cardiogenic pulmonary edema signs). The respiratory rate represents a simple clinical feature that can be used to quantify dyspnea (sign of severity if greater than 30 per minute in adults) and then follow its evolution (improvement, exhaustion). Disorders of consciousness can testify to the severity of the hemodynamic state and/or exhaustion.

Cardiogenic pulmonary edema management without shock implies urgent administration of vasodilators (trinitrin) and intravenous loop diuretics in presence of congestion signs along with the establishment of a system of care adapted to severity (Emergency Mobile Services or ambulance, hospitalization in Intensive Care Unit, intensive cardiology unit, cardiology or medicine department, or emergency passage). The subsequent therapeutic management will especially depend on initial treatment by the primary care physician, so it is preferable to record doses and hours of medications. Non-hospitalization must remain exceptional for non-severe decompensation with rapidly favorable evolution.

The French Observatory of Acute Heart Failure (OFICA) including nearly 1,800 patients specified epidemiological and therapeutic data of patients hospitalized for cardiogenic pulmonary edema in 2009. However, this study did not describe the initial management of the Mobile Emergency and Resuscitation Service and emergency services of hospitals. It is important to note that cardiogenic pulmonary edema initial management is decisive. In addition, early and adapted management of cardiogenic pulmonary edema is associated with a shorter hospital stay and reduced hospital mortality.

The Coronary Emergency Network (RESURCOR) within the Northern French Alps Emergency Network (RENAU) is an emergency care system structured in the departments of Isère, Savoie and Haute-Savoie. Its main goal is to help improve emergency management by using regional good practice guidelines (www.renau.org). In this context, projects aiming to evaluate professional practices are developed regularly. Since emergency management of cardiogenic pulmonary edema has not been evaluated, the Northern French Alps Emergency Network offers an approach to improve professional practices by defining and disseminating a guideline on cardiogenic pulmonary edema management which will then be assessed.

日期

最后验证: 05/31/2019
首次提交: 05/01/2017
提交的预估入学人数: 05/08/2017
首次发布: 05/10/2017
上次提交的更新: 06/13/2019
最近更新发布: 06/17/2019
实际学习开始日期: 12/31/2014
预计主要完成日期: 11/30/2016
预计完成日期: 12/31/2017

状况或疾病

Dyspnea, Paroxysmal
Heart Failure, Left Sided

干预/治疗

Other: Baseline care

Other: Referential's dissemination

-

手臂组

干预/治疗
Baseline care
Patients treated for Cardiogenic Pulmonary Edema into the Northern French Alps Emergency Network between January 1, 2013 and December 31, 2013
Other: Baseline care
Referential's dissemination
Patients treated for Cardiogenic Pulmonary Edema into the Northern French Alps Emergency Network between January 1, 2017 and December 31, 2017, after referential's dissemination for management of patients with paroxysmal dyspnea due to left sided heart failure
Other: Referential's dissemination

资格标准

有资格学习的年龄 18 Years 至 18 Years
有资格学习的性别All
取样方式Non-Probability Sample
接受健康志愿者
标准

Inclusion Criteria:

- ≥18 years old

- hospitalization during one of the two designed period (either year 2013, or year 2017) in a center belonging to Northern French Alps Emergency Network

- diagnosis of cardiogenic pulmonary edema, or heart failure (either left-sided, congestive or unspecified)

Exclusion Criteria:

- people who refuse to have their health information used will not be included

- people whose care will have begun in a center not belonging to the Northern French Alps Emergency Network

结果

主要结果指标

1. Change of quality of initial care of patients with cardiogenic pulmonary edema after dissemination of good practice standards [an average of 1 week (length of hospitalization for cardiogenic pulmonary edema)]

Two kinds of predefined quality indicators will be evaluated at different stages of care and compared among the two periods, before and after dissemination of good practice standards, looking for informations in medical charts during the management of patients either care by Mobile Emergency and Resuscitation Services or at emergency departments and in mails at time of hospital discharge).

次要成果指标

1. Patients' description at the onset of cardiogenic pulmonary edema (clinical) [an average of 1 week (length of hospitalization for cardiogenic pulmonary edema)]

Clinical characteristics of patients with cardiogenic pulmonary edema included in the two parts of this observational study (whole population).

2. Patients' description at the onset of cardiogenic pulmonary edema (biological) [an average of 1 week (length of hospitalization for cardiogenic pulmonary edema)]

Biological characteristics of patients with cardiogenic pulmonary edema included in the two parts of this observational study (whole population).

3. Patients' description at the onset of cardiogenic pulmonary edema (radiological) [an average of 1 week (length of hospitalization for cardiogenic pulmonary edema)]

Radiological characteristics of patients with cardiogenic pulmonary edema included in the two parts of this observational study (whole population).

4. Patients' description at the onset of cardiogenic pulmonary edema (echocardiographic) [an average of 1 week (length of hospitalization for cardiogenic pulmonary edema)]

Echocardiographic characteristics of patients with cardiogenic pulmonary edema included in the two parts of this observational study (whole population).

5. Mortality of patients hospitalized for cardiogenic pulmonary edema [an average of 1 week (length of hospitalization for cardiogenic pulmonary edema)]

number of patients dying during hospitalization for cardiogenic pulmonary edema

6. Needs for Hospitalization in intensive care units [an average of 1 week (length of hospitalization for cardiogenic pulmonary edema)]

number (and rate) of patients with cardiogenic pulmonary edema, requiring hospitalization in intensive care unit

7. Needs for respiratory assistance [an average of 1 week (length of hospitalization for cardiogenic pulmonary edema)]

number of patients and kind of respiratory assistance for patients with cardiogenic pulmonary edema

8. Inter-services transfers [an average of 1 week (length of hospitalization for cardiogenic pulmonary edema)]

number of patients who require transfers from an emergency room (or a cardiology ward) to intensive care units and vice-versa

9. Length of stay in hospital [an average of 1 week (length of hospitalization for cardiogenic pulmonary edema)]

number of days between arrival and discharge

10. Re-hospitalizations during the first six months [up to six months]

number of re-hospitalizations during the first six months after the onset of cardiogenic pulmonary edema

加入我们的脸书专页

科学支持的最完整的草药数据库

  • 支持55种语言
  • 科学支持的草药疗法
  • 通过图像识别草药
  • 交互式GPS地图-在位置标记草药(即将推出)
  • 阅读与您的搜索相关的科学出版物
  • 通过药效搜索药草
  • 组织您的兴趣并及时了解新闻研究,临床试验和专利

输入症状或疾病,并阅读可能有用的草药,输入草药并查看所使用的疾病和症状。
*所有信息均基于已发表的科学研究

Google Play badgeApp Store badge